tradmap

PACB Pacific Biosciences Of California, Inc.

$1.29 -1.52%

Updated

Healthcare · Laboratory Analytical Instruments

Pacific Biosciences Of California, Inc. (PACB) is a healthcare company in the Laboratory Analytical Instruments industry, with a market capitalization of $403 million. Shares last traded at $1.29, 52.6% below their 52-week high. Over the past year the stock is up 2.4%. Net profit margin is -167.1%, below the peer median of -1.7%. Revenue grew 3.9% year over year.

Market Cap
$403M
Shares Out
310.8M
EPS (TTM)
$-3.46
P/E Ratio
P/S Ratio
5.12
P/B Ratio
Dividend / Share
Dividend Yield
52-Week High
$2.73
52-Week Low
$1.07
Volume
249,889
Avg Vol (3m)
297,344.81

Performance

1W
-16.72%
1M
+1.17%
3M
-20.06%
6M
-14.52%
YTD
-30.00%
1Y
+2.37%

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)
47.42
SMA (50)
$1.41
SMA (200)
$1.64
Price vs SMA50
-7.84%
Price vs SMA200
-20.89%
ATR (14)
$0.10

Full technical analysis (26 indicators, D/W/M) →

Financials

Revenue
$79M
Net Income
$-131M
Gross Margin
73.7%
Operating Margin
-169.2%
Net Margin
-167.1%
Return on Equity
395.6%
Return on Assets
-17.5%
Current Ratio
4.92
Debt / Equity
-27.00
Revenue Growth (YoY)
+3.9%

Latest reported annual period ending 2026-06-30 · SEC EDGAR/XBRL.

Full financials — revenue, cash flow & debt over time →

Recent earnings

PeriodEPS (diluted)Reported
Q2 2026 $-0.17 2026-08-06
Q1 2026 $-0.03 2026-05-08
FY 2025 $-1.82 2026-02-25
Q3 2025 $-1.69 2025-11-06
Q2 2026 $-1.57 2026-08-06
Q1 2026 $-1.44 2026-05-08

Full earnings history →

Laboratory Analytical Instruments peers

PACB vs 14 industry peers (Laboratory Analytical Instruments), by market cap. Updated

P/S vs peers
5.12 / 5.01 med
+2% premium
Net margin vs peers
-167.1% / -1.7% med
below median
1–14 of 14
AAgilent Technologies$42.3B29.355.7319.5%-0.93%
WATWaters Corporation$40.6B63.248.7513.8%+0.36%
ILMNIllumina, Inc.$33.5B40.587.4518.4%+3.90%
MTDMettler Toledo$27.2B30.016.5821.9%-0.77%
RVTYRevvity$14.6B61.375.018.2%-0.24%
BIOBio-Rad Laboratories, Inc.$10.4B46.814.028.6%-0.19%
AVTRAvantor, Inc.$10.4B-18.811.58-8.4%+3.65%
BRKRBruker Corp$9.1B-127.122.59-2.0%+0.61%
TXG10x Genomics, Inc.$8.2B-108.5013.21-12.2%+2.45%
ALMRAlamar Biosciences, Inc.$2.1B+0.51%
CTKBCytek Biosciences, Inc.$611M-9.182.96-32.2%+0.21%
MASS908 Devices Inc.$414M-11.956.81-57.0%-3.05%
PACBPacific Biosciences Of California, Inc.$403M-3.06-1.52%
EYPTEyepoint, Inc.$394M-1.28-4.39%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.